• Russia Targets National Database of 1 Million Genomes by 2030

    Aug 07 | Bio-IT World | Russia plans to significantly expand its national database of genetic information by 2030 according to a recent decree approved by the Russian government. As part of the plans, the volume of the already existing database will be increased by 35 times and reach 35 petabytes by 2030. More
  • New Research and Pipeline Updates at Alzheimer’s Conference

    Aug 06 | Bio-IT World | The Alzheimer's Association International Conference was held last week in Toronto and researchers and companies gathered to present their progress in the fight to diagnose and treat Alzheimer’s disease. Among the timely new developments: new products from Quanterix; pre-clinical data from AltPep, OncoC4, and NKGen Biotech; pipeline updates from Eisai, Biogen, and Roche; and more. More
  • XProteome Launches with AI-Powered Protein Corona Platform for Disease Detection

    Aug 05 | Bio-IT World | A new biotech company launched last month with a novel approach to protein discovery that could transform how researchers identify biomarkers and develop treatments for cardiovascular disease, cancer, and neurodegenerative conditions. XProteome, founded by Michigan State University researcher Morteza Mahmoudi, has developed an integrated platform that combines nanomedicine, artificial intelligence, and causality analysis to pinpoint disease-causing proteins with unprecedented precision. More
  • Longitude Prize on ALS Launches, UK Biobank Completes World’s Largest Whole Body Imaging Project, More

    Jul 31 | Bio-IT World | The Longitude Prize on ALS, presented at this year’s Bio-IT World Conference & Expo, has launched to incentivize and reward cutting edge AI-based approaches to transform drug discovery for the treatment of ALS (amyotrophic lateral sclerosis); UK Biobank completed the world’s largest whole body imaging project; and more. More
  • Follow the Money: Universal Flu Vaccine, Full-Length Single-Molecule Protein Sequencer, More

    Jul 30 | Bio-IT World | Centivax plans to get their first universal flu vaccine through a Phase I clinical trial; Portal Biotech will use their nanopore-based platform technology to deliver rapid, full-length, single-molecule protein characterization and expand its R&D, engineering, and data-science teams; and more. More
  • Arab Pangenome Reference Published

    Jul 29 | Bio-IT World | Researchers have published the first draft Arab pangenome reference, the UAE Pangenome Reference (UPR) based on 53 individuals of diverse Arab ethnicities residing in the United Arab Emirates. The work was done at the Center for Applied and Translational Genomics (CATG), Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates and was published in Nature Communications last week. More
  • Multiomics Platform Integration Advances Cancer Treatment Predictions

    Jul 24 | Bio-IT World | A groundbreaking biotech collaboration in Switzerland has successfully integrated nine molecular analysis platforms to create a comprehensive tumor profiling system that predicts optimal cancer treatments—showcasing how next-generation sequencing can be enhanced through multiomics approaches for transformative clinical outcomes. More
  • Innovative Practices Award for NHS England, IQVIA Privacy Protection Platform

    Jul 23 | Bio-IT World | To support patient privacy while providing data accessibility for organizations, the National Health Service (NHS) England with IQVIA developed NHS PET (Privacy Enhancing Technology) as a secure, scalable solution for patient data. The work earned NHS and IQVIA one of four Innovative Practices Awards at this year’s Bio-IT World Conference & Expo—an honor the judges christened the “Respect the Patient Award”. More
  • NIST Releases First Cancer Cell Line for Public Genomic Research

    Jul 22 | Bio-IT World | The National Institute of Standards and Technology (NIST) has released the first cancer cell line in its Genome in a Bottle (GIAB) consortium. The new resource features a pancreatic cancer tumor cell line along with corresponding normal tissue samples, all obtained with explicit patient consent for public genomic data sharing. More
  • The New Frontier in Alzheimer’s Prevention: AI-Powered Neurodiagnostic Solutions

    Jul 18 | Bio-IT World | Imagine sitting down for a routine checkup and learning you could prevent one of the most devastating diseases of our time before it ever occurs. For many families, diagnosis arrives only after noticeable confusion or memory loss disrupts daily life. By that point, much of the brain has already been damaged, and options for slowing decline are limited. More
View more articles
Bio IT World Lead Gen

 
Industry-spotlight

Riffyn’s pioneering cloud system, Riffyn Nexus, delivers 2X faster development cycles and 4X productivity gains to the world’s most advanced scientific R&D organizations. Its process-centric experiment design, data capture, and data analytics overcome the limitations of ELN and LIMS systems. Its adaptive data integration engine delivers results that are always ready for machine learning.
Read more here!

Industry-spotlight
Trends from the Trenches

Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next.
Listen today!